As I expected, I was able to buy back in today after the release of results, and without having to pay a premium (in fact I got a discount). Very uncommon, but this stock is ignored by the market, and perhaps in the case of this trial, the small number of participants and the unclear path to FDA approval is causing the SP to not react in the way you would hope and expect with the release of positive ph2 results
Ann: Invion - successful completion of P2 study of INV102, page-14
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.29M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $26.46K | 8.821M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 8542671 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 11009899 | 16 |
View Market Depth
| Last trade - 11.36am 14/10/2024 (20 minute delay) ? |
| IVX (ASX) Chart |